David George Young, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1361 N Lake Park Blvd, Carolina Beach, NC 28428 Phone: 910-458-4172 Fax: 910-458-6748 |
Kenneth Weaver, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1361 Lake Park Blvd N, Carolina Beach, NC 28428 Phone: 910-458-4172 |
Marsha B Winstead Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 901 Dow Rd, Carolina Beach, NC 28428 Phone: 910-458-3060 Fax: 910-458-2785 |
Martha Ann Dancy Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 901 Dow Rd, Carolina Beach, NC 28428 Phone: 910-458-3060 |
Daniel A Wittman, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1361 Lake Park Blvd N, Carolina Beach, NC 28428 Phone: 910-458-4172 |
Ms. Jeanie Lynn Sadler Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 211 Georgia Ave, Carolina Beach, NC 28428 Phone: 540-847-7979 |
Jeanne L Mcevoy Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 901 Dow Rd, Carolina Beach, NC 28428 Phone: 910-458-3060 Fax: 910-458-2782 |
Sabra L Quarles, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1361 N Lake Park Blvd, Carolina Beach, NC 28428 Phone: 910-458-4172 |
Mrs. Lauralyle Johnson Weaver, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 901 Dow Rd, Carolina Beach, NC 28428 Phone: 910-458-3060 |
News Archive
Foundation Medicine, Inc., a molecular information company that brings comprehensive cancer genomic analysis to routine clinical care, today announced results from two studies using next-generation sequencing (NGS) to provide actionable information about genomic tumor alterations in individual patients' cancers across all solid tumor types.
More than 20 million people in the U.S., and many more worldwide, who have been exposed to asbestos are at risk of developing mesothelioma, a malignant cancer of the membranes that cover the lungs and abdomen that is resistant to current therapies.
April 16 was a big day for Moderna, a Massachusetts biotech company on the verge of becoming a front-runner in the U.S. government's race for a coronavirus vaccine. It had received roughly half a billion dollars in federal funding to develop a COVID shot that might be used on millions of Americans.
Mammogram readings by both radiologists and non-physician technologists improve breast cancer detection rates, according to a study in the July 24 Journal of the National Cancer Institute.
TONIX Pharmaceuticals Holding Corp., a specialty pharmaceutical company developing therapies for challenging disorders of the central nervous system, including fibromyalgia syndrome and post-traumatic stress disorder, has received net proceeds of approximately $1.9 million in a private placement offering to institutional and accredited investors.
› Verified 3 days ago